By www.reliableresearchiq.com
Global And United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Report & Forecast 2024-2031 Story
105
$ 4350
Squamous Non-Small Cell Lung Cancer Therapeutics Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Ascenta Therapeutics, Inc. AstraZeneca Plc AVEO Pharmaceuticals, Inc. Bayer AG BIND Therapeutics, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Eli Lilly and Company F. Hoffmann-La Roche Ltd. Five Prime Therapeutics, Inc. Genentech, Inc. Incyte Corporation Johnson & Johnson MacroGenics, Inc. Novartis AG Oncogenex Pharmaceuticals, Inc. PsiOxus Therapeutics Limited